Literature DB >> 26872578

When should video and EMG be added to urodynamics in children with lower urinary tract dysfunction and is this justified by the evidence? ICI-RS 2014.

Ralf Anding1, Phillip Smith2, Tom de Jong3, Christos Constantinou4, Linda Cardozo5, Peter Rosier6.   

Abstract

AIMS: An ICI-RS Think Tank in 2014 discussed and evaluated the evidence for adding video and EMG to urodynamics (UDS) in children and also highlighted evidence gaps, with the aim of recommending further clinical and research protocols.
METHODS: A systematic analysis of the relevant literature for both X-ray (video) studies and electromyography, in combination with UDS in children with lower urinary tract dysfunction (LUTD), is summarized in this manuscript. The technical aspects are also critically reviewed.
RESULTS: The body of evidence for the addition of X-ray (video) to filling and voiding cystometry and the evidence for the addition of pelvic muscle surface electromyography to urodynamics is scanty and insufficient. Standards are poor and variable so uncontrolled expert opinion dominates practice.
CONCLUSIONS: The Think Tank has recommended that standardized ALARA ("As Low As Reasonably Achievable") principles should be adopted for video-urodynamics in children. The risk-benefit balance of X-ray exposure needs to be better evaluated and defined. Evaluation of images should be standardized and the association with pressure changes better analyzed and reported. Children's pelvic muscle surface electromyography technique should be standardized, technically improved, and its diagnostic relevance should be better evaluated.
© 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  EMG; X-ray; children; lower urinary tract dysfunction; video-urodynamics

Mesh:

Year:  2016        PMID: 26872578     DOI: 10.1002/nau.22894

Source DB:  PubMed          Journal:  Neurourol Urodyn        ISSN: 0733-2467            Impact factor:   2.696


  1 in total

Review 1.  The Role of Video Urodynamics in the Management of the Valve Bladder.

Authors:  Charles W Concodora; Pramod P Reddy; Brian A VanderBrink
Journal:  Curr Urol Rep       Date:  2017-03       Impact factor: 3.092

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.